Tytgat G - Search Results

1

Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease.

Hommes D, van den Blink B, Plasse T, Bartelsman J, Xu C, Macpherson B, Tytgat G, Peppelenbosch M, Van Deventer S. Hommes D, et al. Among authors: tytgat g. Gastroenterology. 2002 Jan;122(1):7-14. doi: 10.1053/gast.2002.30770. Gastroenterology. 2002. PMID: 11781274 Clinical Trial.

2

CD4 antibody treatment in Crohn's disease.

Stronkhorst A, Tytgat GN, van Deventer SJ. Stronkhorst A, et al. Among authors: tytgat gn. Scand J Gastroenterol Suppl. 1992;194:61-5. doi: 10.3109/00365529209096029. Scand J Gastroenterol Suppl. 1992. PMID: 1298050

3

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J. van Dullemen HM, et al. Among authors: tytgat gn. Gastroenterology. 1995 Jul;109(1):129-35. doi: 10.1016/0016-5085(95)90277-5. Gastroenterology. 1995. PMID: 7797011 Clinical Trial.

4

Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride.

Boeckxstaens GE, Bartelsman JF, Lauwers L, Tytgat GN. Boeckxstaens GE, et al. Among authors: tytgat gn. Am J Gastroenterol. 2002 Jan;97(1):194-7. doi: 10.1111/j.1572-0241.2002.05396.x. Am J Gastroenterol. 2002. PMID: 11811166

5

Long term results of pneumatic dilation in achalasia followed for more than 5 years.

West RL, Hirsch DP, Bartelsman JF, de Borst J, Ferwerda G, Tytgat GN, Boeckxstaens GE. West RL, et al. Among authors: tytgat gn. Am J Gastroenterol. 2002 Jun;97(6):1346-51. doi: 10.1111/j.1572-0241.2002.05771.x. Am J Gastroenterol. 2002. PMID: 12094848

6

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection.

Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Noach LA, et al. Among authors: tytgat gn. Scand J Gastroenterol. 1994 May;29(5):425-9. doi: 10.3109/00365529409096833. Scand J Gastroenterol. 1994. PMID: 8036458

7

Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein.

Monajemi H, Meenan J, Lamping R, Obradov DO, Radema SA, Trown PW, Tytgat GN, Van Deventer SJ. Monajemi H, et al. Among authors: tytgat gn. Gastroenterology. 1996 Mar;110(3):733-9. doi: 10.1053/gast.1996.v110.pm8608882. Gastroenterology. 1996. PMID: 8608882

8

Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis.

Meenan J, Grool TA, Hommes DW, Dijkhuizen S, ten Kate FJ, Wood M, Whittaker M, Tytgat GN, van Deventer SJ. Meenan J, et al. Among authors: tytgat gn. Eur J Gastroenterol Hepatol. 1996 Jun;8(6):569-73. doi: 10.1097/00042737-199606000-00014. Eur J Gastroenterol Hepatol. 1996. PMID: 8823572

9

Attenuation of the inflammatory response in an animal colitis model by neutrophil inhibitory factor, a novel beta 2-integrin antagonist.

Meenan J, Hommes DW, Mevissen M, Dijkhuizen S, Soule H, Moyle M, Büller HR, ten Kate FW, Tytgat GN, van Deventer SJ. Meenan J, et al. Among authors: tytgat gn. Scand J Gastroenterol. 1996 Aug;31(8):786-91. doi: 10.3109/00365529609010353. Scand J Gastroenterol. 1996. PMID: 8858748

10

Previous use of non-steroidal anti-inflammatory drugs and anticoagulants: the influence on clinical outcome of bleeding gastroduodenal ulcers.

Vreeburg EM, de Bruijne HW, Snel P, Bartelsman JW, Rauws EA, Tytgat GN. Vreeburg EM, et al. Among authors: tytgat gn. Eur J Gastroenterol Hepatol. 1997 Jan;9(1):41-4. doi: 10.1097/00042737-199701000-00011. Eur J Gastroenterol Hepatol. 1997. PMID: 9031897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,015 results

Search Page

Filters